Futura Medical PLC (LSE:FUM) - Share price - Overview

Stock Report

Futura Medical PLC FUM

Last Price
GBX34.38

Day Change
-2.87|-7.70%

As of 24/08/2017
11:30:51 BST | GBX
Minimum 15 Minutes Delay.

Last Close37.25p
Day Range33.09 - 37.30
Mkt Cap44.94Mil
52-Wk Range28.20 - 95.60
Yield %0.00
ISINGB0033278473
Volume1,039,410
P/E-9.42
P/S204.64
P/CF-10.66

Share Price

Total Returns 23/08/2017

 Chg (%)  
More ...
Futura Medical PLC-32.27 
FTSE 100 TR GBP-0.13
 
Financials
201420152016
More ...
Income Statement
Turnover0.040.030.17
Operating Profit-3.53-6.12-4.55
Net Profit-3.00-5.08-3.70
Reported EPS-3.35-5.13-3.65
Balance Sheet
Current Assets10.325.5013.42
Non Current Assets0.010.020.02
Total Assets10.335.5213.44
Current Liabilities0.610.730.86
Total Liabilities0.610.730.86
Total Equity9.724.7912.58
Cash Flow
Operating Cash Flow-3.38-5.84-4.30
Net Change in Cash8.50-5.308.17
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-7.81-5.04--7.40---
20181.64-0.90--41.62---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/01/2017Transfer OutJames Barder0.0050,0000.00
12/01/2017Sale of Option SharesJames Barder55.17210,000115,861.00
12/01/2017Exercise of OptionJames Barder40.50250,000101,250.00
12/01/2017Sale of Option SharesDerek Martin55.17100,00055,172.00

Company Profile

Futura Medical PLC is a UK based drug manufacturer. Its business is to manufacture pharmaceutical products mainly for the treatment of erectile dysfunction and a measure against pain relief.

Sector

Drug Manufacturers - Major

Market Position

1081 of 1847 Companies

Index

FTSE AIM All Share

Outlook

(14/06/2017) ch - "...we look forward to the year ahead with confidence"

Next Event 12/09/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-15.6513.7416.90
Div Yld (E)0.004.014.18
PEG (E)0.000.661.11
ROCE-36.07183.51201.78
Op Mrgn-2,678.82-6.26-105.96
EPS Grwth0.0027.4923.19
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Clarke
Chief ExecutiveJames Barder
Finance Director & Company SecretaryDerek Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.